EGFR-IN-26
Modify Date: 2025-08-20 19:31:57
EGFR-IN-26 structure
|
Common Name | EGFR-IN-26 | ||
|---|---|---|---|---|
| CAS Number | 2375470-64-5 | Molecular Weight | 514.62 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C29H34N6O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of EGFR-IN-26EGFR-IN-26 is a EGFR inhibitor extracted from patent WO2019162323A1 compound I-028. EGFR-IN-26 can be used for the research of cancer[1]. |
| Name | EGFR-IN-26 |
|---|
| Description | EGFR-IN-26 is a EGFR inhibitor extracted from patent WO2019162323A1 compound I-028. EGFR-IN-26 can be used for the research of cancer[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. BOESE D, et, al. New benzimidazole compounds and derivatives as egfr inhibitors. WO2019162323A1. |
| Molecular Formula | C29H34N6O3 |
|---|---|
| Molecular Weight | 514.62 |